These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12818266)

  • 1. Effects of 6-12 months of esomeprazole treatment on the gastric mucosa.
    Genta RM; Rindi G; Fiocca R; Magner DJ; D'Amico D; Levine DS
    Am J Gastroenterol; 2003 Jun; 98(6):1257-65. PubMed ID: 12818266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological and functional recovery in patients with multifocal atrophic gastritis after eradication of Helicobacter pylori infection.
    Savarino V; Mela GS; Zentilin P; Lapertosa G; Bisso G; Mele MR; Pivari M; Mansi C; Vigneri S; Celle G
    Ital J Gastroenterol Hepatol; 1999; 31(1):4-8. PubMed ID: 10091096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trial.
    Fiocca R; Mastracci L; Attwood SE; Ell C; Galmiche JP; Hatlebakk J; Bärthel A; Långström G; Lind T; Lundell L;
    Aliment Pharmacol Ther; 2012 Nov; 36(10):959-71. PubMed ID: 22998687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of gastritis in patients with Helicobacter pylori-positive reflux esophagitis.
    Mihara T; Adachi K; Komazawa Y; Yoshida M; Araki A; Maruyama R; Furuta K; Ishihara S; Amano Y; Kinoshita Y
    J Gastroenterol Hepatol; 2005 May; 20(5):682-7. PubMed ID: 15853979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety.
    Johnson DA; Benjamin SB; Vakil NB; Goldstein JL; Lamet M; Whipple J; Damico D; Hamelin B
    Am J Gastroenterol; 2001 Jan; 96(1):27-34. PubMed ID: 11197282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia?
    Xia HH; Kalantar JS; Talley NJ; Wyatt JM; Adams S; Chueng K; Mitchell HM
    Am J Gastroenterol; 2000 Jan; 95(1):114-21. PubMed ID: 10638568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptom response and healing of erosive esophagitis with proton-pump inhibitors in patients with Helicobacter pylori infection.
    Vakil NB; Traxler BM; Levine D
    Am J Gastroenterol; 2004 Aug; 99(8):1437-41. PubMed ID: 15307856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
    Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
    Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing corpus argyrophil cell density and hyperplasia in reflux esophagitis patients treated with antisecretory drugs and controls.
    Diebold MD; Richardson S; Duchateau A; Bigard MA; Colin R; Cortot A; Fauchère JL; Zeitoun P
    Dig Dis Sci; 1998 Aug; 43(8):1629-35. PubMed ID: 9724142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of esomeprazole triple therapy on eradication rates of Helicobacter pylori, gastric ulcer healing and prevention of relapse in gastric ulcer patients.
    Tulassay Z; Stolte M; Sjölund M; Engstrand L; Butruk E; Malfertheiner P; Dite P; Tchernev K; Wong BC; Gottlow M; Eklund S; Wrangstadh M; Nagy P
    Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):526-36. PubMed ID: 18467912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H. pylori eradication prevents the progression of gastric intestinal metaplasia in reflux esophagitis patients using long-term esomeprazole.
    Yang HB; Sheu BS; Wang ST; Cheng HC; Chang WL; Chen WY
    Am J Gastroenterol; 2009 Jul; 104(7):1642-9. PubMed ID: 19436275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: a long-term prospective cohort study.
    Toyokawa T; Suwaki K; Miyake Y; Nakatsu M; Ando M
    J Gastroenterol Hepatol; 2010 Mar; 25(3):544-7. PubMed ID: 19817964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status.
    Sozzi M; Valentini M; Figura N; De Paoli P; Tedeschi RM; Gloghini A; Serraino D; Poletti M; Carbone A
    Am J Gastroenterol; 1998 Mar; 93(3):375-9. PubMed ID: 9517643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication.
    Kuipers EJ; Lundell L; Klinkenberg-Knol EC; Havu N; Festen HP; Liedman B; Lamers CB; Jansen JB; Dalenback J; Snel P; Nelis GF; Meuwissen SG
    N Engl J Med; 1996 Apr; 334(16):1018-22. PubMed ID: 8598839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effects of eradication therapy in patients with chronic atrophic gastritis and seropositivity for anti-HP antibodies and histological negativity for Helicobacter pylori].
    Leri O; Mastropasqua M; Scopelliti G; Grasso E; Losi T; Iadicicco A; Perinelli P
    Clin Ter; 1999; 150(5):343-6. PubMed ID: 10687264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cure of Helicobacter pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinemia and its related effects on body ECL-cell hyperplasia.
    Annibale B; Aprile MR; D'ambra G; Caruana P; Bordi C; Delle Fave G
    Aliment Pharmacol Ther; 2000 May; 14(5):625-34. PubMed ID: 10792127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Helicobacter pylori infection and gastric mucosal abnormalities in chronic pancreatitis.
    Manes G; Dominguez-Muñoz JE; Hackelsberger A; Leodolter A; Rössner A; Malfertheiner P
    Am J Gastroenterol; 1998 Jul; 93(7):1097-100. PubMed ID: 9672337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healing of erosive esophagitis and improvement of symptoms of gastroesophageal reflux disease after esomeprazole treatment in children 12 to 36 months old.
    Tolia V; Gilger MA; Barker PN; Illueca M
    J Pediatr Gastroenterol Nutr; 2010 Nov; 51(5):593-8. PubMed ID: 20706150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic inflammation at the gastroesophageal junction (carditis) appears to be a specific finding related to Helicobacter pylori infection and gastroesophageal reflux disease. The Central Finland Endoscopy Study Group.
    Voutilainen M; Färkkilä M; Mecklin JP; Juhola M; Sipponen P
    Am J Gastroenterol; 1999 Nov; 94(11):3175-80. PubMed ID: 10566710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori-negative gastritis in erosive esophagitis, nonerosive reflux disease or functional dyspepsia patients.
    Peura DA; Haber MM; Hunt B; Atkinson S
    J Clin Gastroenterol; 2010 Mar; 44(3):180-5. PubMed ID: 19687753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.